Sectoral Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Hold |
|
|||||
|
2025
Q1 | $1.66M | Sell |
|
|||||
|
2024
Q4 | $1.93M | Sell |
|
|||||
|
2024
Q3 | $2.59M | Sell |
|
|||||
|
2024
Q2 | $3.4M | Sell |
|
|||||
|
2024
Q1 | $4.51M | Buy |
|
|||||
|
2023
Q4 | $4.83M | Sell |
|
|||||
|
2023
Q3 | $12.8M | Sell |
|
|||||
|
2023
Q2 | $12.9M | Buy |
|
|||||
|
2023
Q1 | $12.1M | Sell |
|
|||||
|
2022
Q4 | $14.4M | Sell |
|
|||||
|
2022
Q3 | $13.8M | Buy |
|
|||||
|
2022
Q2 | $11.7M | Buy |
|
|||||
|
2022
Q1 | $8.11M | Buy |
|
|||||
|
2021
Q4 | $895K | Sell |
|
|||||
|
2021
Q3 | $8.2M | Buy |
|
|||||
|
2021
Q2 | $6.07M | Sell |
|
|||||
|
2021
Q1 | $6.61M | Sell |
|
|||||
|
2020
Q4 | $8.49M | Sell |
|
|||||
|
2020
Q3 | $11.5M | Buy |
|
|||||
|
2020
Q2 | $16.2M | Sell |
|
|||||
|
2020
Q1 | $15.5M | Sell |
|
|||||
|
2019
Q4 | $18.9M | Buy |
|
|||||
|
2019
Q3 | $9.56M | Sell |
|
|||||
|
2019
Q2 | $13.1M | Buy |
|
|||||
|
2019
Q1 | $7.13M | Sell |
|
|||||
|
2018
Q4 | $7.8M | Sell |
|
|||||
|
2018
Q3 | $17.9M | Sell |
|
|||||
|
2018
Q2 | $24.5M | Sell |
|
|||||
|
2018
Q1 | $32.3M | Buy |
|
|||||
|
2017
Q4 | $23.1M | Buy |
|
|||||
|
2017
Q3 | $22.2M | Sell |
|
|||||
|
2017
Q2 | $28.5M | Sell |
|
|||||
|
2017
Q1 | $27.7M | Sell |
|
|||||
|
2016
Q4 | $40.8M | Buy |
|
|||||
|
2016
Q3 | $38.1M | Sell |
|
|||||
|
2016
Q2 | $38.5M | Sell |
|
|||||
|
2016
Q1 | $123M | Buy |
|
|||||
|
2015
Q4 | $142M | Buy |
|
|||||
|
2015
Q3 | $102M | Buy |
|
|||||
|
2015
Q2 | $132M | Sell |
|
|||||
|
2015
Q1 | $176M | Buy |
|
|||||
|
2014
Q4 | $113M | Sell |
|
|||||
|
2014
Q3 | $99.5M | Buy |
|
|||||
|
2014
Q2 | $72.7M | Buy |
|
|||||
|
2014
Q1 | $63.3M | Buy |
|
|||||
|
2013
Q4 | $50.2M | Sell |
|
|||||
|
2013
Q3 | $52.1M | Sell |
|
|||||
|
2013
Q2 | $110M | Buy |
|